Maghinay, Anna Taylor .

HRN: 18-61-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFUROXIME 1.5GM (VIAL)
04/01/2023
04/07/2023
IVT
250mg
Q8
Urti
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: